Urologix Inc (ULGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,547 | -950 | -677 | -4,419 | -3,545 |
| Depreciation Amortization | 616 | 422 | 218 | 973 | 759 |
| Accounts receivable | -358 | -326 | -504 | 256 | 200 |
| Accounts payable and accrued liabilities | 103 | 21 | 118 | -312 | -244 |
| Other Working Capital | -644 | -721 | -691 | -1,019 | -977 |
| Other Operating Activity | 626 | 574 | 523 | 600 | 458 |
| Operating Cash Flow | $-1,204 | $-980 | $-1,013 | $-3,921 | $-3,349 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65 | -51 | -38 | -86 | -55 |
| Purchase Sale Intangibles | -9 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -9 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-74 | $-51 | $-38 | $-86 | $-55 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10 | 10 | 8 | 8 | 8 |
| Financing Cash Flow | $10 | $10 | $8 | $8 | $8 |
| Beginning Cash Position | 7,032 | 7,032 | 7,032 | 11,031 | 11,031 |
| End Cash Position | 5,764 | 6,011 | 5,989 | 7,032 | 7,635 |
| Net Cash Flow | $-1,268 | $-1,021 | $-1,043 | $-3,999 | $-3,396 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,204 | -980 | -1,013 | -3,921 | -3,349 |
| Capital Expenditure | -65 | -51 | -38 | -86 | -55 |
| Free Cash Flow | -1,269 | -1,031 | -1,051 | -4,007 | -3,404 |